Even moderate weight loss can improve blood pressure, cholesterol levels, and insulin sensitivity
#Healthcare #HealthcareInnovation #DigitalHealth #Pharma #PharmaIndia #GLP1 #Semaglutide #Diabetes #DiabetesCare #Obesity #MedTech #HealthTech #IndianHealthcare #Innovation #FutureOfHealthcare To view or add a comment, sign in A debate over the adoption of GLP-1 weight-loss drugs in India has intensified after Biocon Executive Chairperson Kiran Mazumdar-Shaw cautioned against their widespread use among healthy individuals, responding to Zerodha Founder and CEO Nithin Kamath's observations on weaker-than-expected demand for generic versions of the medicines
Its primary role is to protect cells from oxidative stress and free-radical damage, which are key contributors to dull skin, aging, and several chronic health issues
Semaglutide, when added to diet and exercise, resulted in 15 to 20% weight loss, but it also comes with potential risks and should be obtained through proper medical channels
Comparison of DNA and RNA analyte extraction and melanin removal methods from formalin-fixed parraffin-embedded (FFPE) melanoma
